• Home
  • Technology
  • About
  • Newsroom
  • Contact
Menu
  • Home
  • Technology
  • About
  • Newsroom
  • Contact

Category: News

<font color="#4B9CD2"> Genomeweb: </font> Genomill Health Positioning Geno1 Technology to Improve Liquid Biopsy Sequencing

 NEW YORK – After closing an investment round last month for an undisclosed sum, Finnish firm Genomill Health is aiming to broaden adoption of its Geno1 technology, a barcoding-based method that it believes can enhance sequencing accuracy and lower costs and turnaround time for applications with high sensitivity and efficiency demands like liquid biopsy.  The […]

Genomill Health closes investment round to expand beta-testing with liquid biopsy players

Genomill Health closes a financing round led by a deep tech VC Voima Ventures to expand its novel and disruptive technology, focusing on efficient use of NGS (next generation sequencing) in liquid biopsies for cancer diagnostics.

info@genomill.com

  • Home
  • Technology
  • About
  • Newsroom
  • Contact
Menu
  • Home
  • Technology
  • About
  • Newsroom
  • Contact
Linkedin Crunchbase icon

COPYRIGHT 2021 GENOMILL HEALTH OY | BUSINESS ID 2727877-4